Metabolism of Tac (IL2Rα): Physiology of cell surface shedding and renal catabolism, and suppression of catabolism by antibody binding

Journal of Experimental Medicine

Volumn 183, Issue 4, 1996, Pages 1587-1602

  Junghans, R P ^a   Waldmann, T A ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE PROTEIN; INTERLEUKIN 2 RECEPTOR; IODINE 125; IODINE 131; RECOMBINANT PROTEIN; ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN ANTIBODY COMPLEX; ANTIGEN BINDING; ARTICLE; CANCER CELL CULTURE; CATABOLISM; CELL SURFACE; HALF LIFE TIME; HUMAN; HUMAN CELL; ISOTOPE LABELING; KIDNEY METABOLISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN METABOLISM; RECEPTOR BINDING; T LYMPHOCYTE ACTIVATION; ANIMAL; ANTIGEN ANTIBODY REACTION; BIOLOGICAL MODEL; CARDIOVASCULAR SYSTEM; CELL CULTURE; CELL MEMBRANE; IMMUNOLOGY; KIDNEY; KINETICS; METABOLISM; NUDE MOUSE; SOLUBILITY; TRANSPORT AT THE CELLULAR LEVEL; UPREGULATION;

ANIMALS; ANTIBODIES; ANTIGEN-ANTIBODY REACTIONS; BIOLOGICAL TRANSPORT; CARDIOVASCULAR SYSTEM; CELL MEMBRANE; HALF-LIFE; HUMANS; KIDNEY; KINETICS; MICE; MICE, NUDE; MODELS, BIOLOGICAL; RECEPTORS, INTERLEUKIN-2; SOLUBILITY; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0029665818     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.4.1587     Document Type: Article

References (60)

1. Fernandez-Botran, R. 1991. Soluble cytokine receptors: their role in immunoregulation. FASEB (Fed. Am. Soc. Exp. Biol.) J. 5:2567-2574.
2. Gearing, A.J.H., and W. Newman. 1993. Circulating adhesion molecules in disease. Immunol Today. 14.506-509.
3. Schwartz, M.K. 1993. Cancer markers. In Cancer: Principles and Practice of Oncology. 4th ed. V.T. Devita, S. Hellman, and S.A. Rosenberg, editors. Lippincott, Philadelphia. 531-542.
4. Arend, W.R. 1995. Inhibiting the effects of cytokines in human disease. Adv. Intern. Med. 40:365-394.
5. Junghans, R.P., G. Sgouros, and D.B. Scheinberg. 1996. Antibody-based immunotherapies in cancer. In Cancer Chemotherapy and Biotherapy: Principles and Practice. B.A. Chabner and D.L. Longo, eds. Lippincott-Raven Publ., Philadelphia. 655-689.
6. Ehlers, M.R.W., and J.F. Riordan. 1991. Membrane proteins with soluble counterparts: role of proteolysis in the release of transmembrane proteins. Biochemistry. 30:10065-10074.
7. Waldmann, T.A., I.H. Pastan, O.A. Gansow and R.P. Junghans. 1992. The multichain interleukin-2 receptor. a target for immunotherapy. Ann. Intern. Med. 116:148-160.
8. Greene, W.C., W.J. Leonard, J.M. Depper, D.L. Nelson, and T.A. Waldmann. 1986. The human interleukin-2 receptor: normal and abnormal expression in T cells and in leukemias induced by the human T-lymphotropic retroviruses. Ann. Intern. Med. 105:560-572.
9. Robb, R.J., and R.M. Kutny. 1987. Structure-function relationships for the IL2-receptor system. J. Immunol. 139:855-862.
10. Simpson, M.A., P.N. Madras, A.J. Cornaby, T. Etienne, R.A. Dempsey, G.H. Clowes, and A.P. Monaco. 1989. Sequential determinations of urinary cytology and plasma and urinary lymphokines in the management of renal allograft recipients. Transplantation (Baltimore). 47:218-223.
11. Lawrence, E.C., V.A. Holland, J.B. Young, and N.T. Windsor. 1989. Dynamic changes in soluble interleukin-2 receptor levels after lung or heart-lung transplantation. Am. Rev. Respir. Dis. 140:789-796.
12. Semenzato, G., L.M. Bambara, D. Biasi, A. Frigo, F. Vinante, B. Zuppim, L. Trentin, C. Feruglio, M. Chilosi, and G. Pizzolo. 1988. Increased serum levels of soluble interleukin-2 receptor in patients with systemic lupus erythematosus and rheumatoid arthritis. J. Clin. Immunol. 8:447-452.
13. Marcon, L., M.E. Fritz, C.C. Kurman, J.C. Jensen, and D.L. Nelson. 1988. Soluble Tac peptide is present in the urine of normal individuals and at elevated levels in patients with adult T cell leukemia (ATL). Clin. Exp. Immunol. 73:29-33.
14. Rubin, L.A., G.S. Hekzema, D.L. Nelson, W.C. Greene, and G. Jay. 1987. Reconstitution of a functional interleukin 2 receptor in a nonlymphoid cell. J. Immunol. 139:2355-2360.
15. Ambrosetti, A., G. Semenzato, M. Prior, M. Chilosi, F. Vinante, C. Vincenzi, R. Zanotti, L. Trentin, A. Portuese, F. Menestrina, et al. 1989. Serum levels of soluble interleukin-2 receptor in hairy cell leukemia: a reliable marker of neoplastic bulk. Br. J. Haematol. 73:181-186.
16. Meeker, T.C., D.G. Maloney, R.A. Miller, K. Thielmans, R. Warnke, and R. Levy. 1985. A clinical trial of anti-idiotype therapy for B cell malignancy. Blood. 65:1349-1363.
17. Schulz, G., D.A. Cheresh, N.M. Varki, A. Yu, L.K. Staffileno, and R.A. Reisfeld. 1984. Detection of ganglioside GD2 in tumor tissues and sera of neuroblastoma patients. Cancer Res. 44:5914-5920.
18. Sela, B.-A., D. Iliopoulos, D. Ghuerry, D. Herlyn, and H. Koprowski. 1989. Levels of disialogangliosides in sera of melanoma patients monitored by sensitive thin layer chromatography and immunostaining. J. Natl. Cancer Inst. 81:1489-1492.
19. Sharkey, R.M., D.M. Goldenberg, H. Goldenberg, R.E. Lee, C. Ballance, K.D. Pawly, D. Varga, and H.J. Hansen. 1990. Murine monoclonal antibodies against carcinoembryonic antigen; immunological, pharmacokinetic, and targeting properties in humans. Cancer Res. 50:2823-2831.
20. 212Bi) radioimmunotherapy. Cancer Res. 53:5683-5689.
21. Nelson, D.L. 1986. Expression of a soluble form of the interleukin-2 receptor in normal and neoplastic states. The human interleukin-2 receptor: normal and abnormal expression in cells and in leukemias induced by the human T-lymphotropic retroviruses. Ann. Intern. Med. 105:560-572.
22. Jacques, Y., B. LeMauff, F. Boeffard, A. Godard, and J.P. Soulillou 1987. A soluble interleukin 2 receptor produced by a normal alloreactive human T cell clone binds interleukin 2 with low affinity. J. Immunol. 139:2308-2316.
23. Wochner, R.D., W. Strober, and T.A. Waldmann. 1967. The role of the kidney in the catabolism of Bence Jones proteins and immunoglobulin fragments. J. Exp. Med. 126:207-221.
24. Mogielnicki, P.R., T.A. Waldmann, and W. Strober. 1971. Renal handling of molecular weight proteins. I. L-chain metabolism in experimental renal disease. J. Clin. Invest. 50:901-909.
25. Chang, A.E., C.L. Hyatt, and S.A. Rosenberg. 1984. Systemic administration of recombinant human interleukin 2 in mice. J. Biol. Response Modif. 3:561-572.
26. Depper, J.M., W.J. Leonard, M. Kronke, P.D. Noguchi, R.E. Cunningham, T.A. Waldmann, and W.C. Greene. 1984. Regulation of interleukin 2 receptor expression: effects of phorbal diester, phospholipase C, and reexposure to lectin or antigen. J. Immunol. 133:3054-3061.
27. Leonard, W.J., J.M. Depper, G.R. Crabtree, S. Rudikoff, J. Pumphrey, R.J. Robb, M. Kronke, P.B. Svetlik, N.J. Peffer, T.A. Waldmann, and W.C. Greene. 1984. Molecular cloning and expression of cDNAs for the human interleukin-2 receptor. Nature (Lond). 311:626-631.
28. Leonard, W.J., M. Kronke, N.J. Peffer, J.M. Depper, and W.C. Greene. 1985. Interleukin-2 receptor gene expression in normal human T lymphocytes. Proc. Natl. Acad. Sci. USA. 82:6281-6285.
29. Cullen, B.R., F.J. Podlaski, N.J. Peffer, J.B. Hosking, and W.C. Greene. 1988. Sequence requirements for ligand binding and cell surface expression of the Tac antigen, a human interleukin-2 receptor. J. Biol. Chem. 263:4900-4906.
30. Uchiyama, T., T. Hori, M. Tsudo, Y. Wano, H. Umadome, S. Tamori, J. Yodoi, M. Maeda, H. Sawami, and H. Uchino. 1985. Interleukin-2 receptor (Tac antigen) expressed on adult T cell leukemia cells. J. Clin. Invest. 76:446-453.
31. Waldmann, T.A., and W. Strober. 1969. Metabolism of immunoglobulins. Prog. Allergy. 13:1-110.
32. Humphrey, J.H., and J.L. Fahey. 1961. The metabolism of normal plasma proteins and gamma-myeloma protein in mice bearing plasma-cell tumors. J. Clin. Invest. 40:1696-1705.
33. Waldmann, T.A., W. Strober, and P.R. Mogielnicki. 1972. The renal handling of low molecular weight proteins. II. Disorders of serum protein catabolism in patients with tubular proteinuria, the nephrotic syndrome, or uremia. J. Clin. Invest. 51:2162-2174.
34. 33a.Junghans, R.P., A.L. Stone, and M.S. Lewis. 1996. Biophysical characterization of a recombinant soluble interleukin 2 receptor (Tac): evidence for a monomeric structure. J. Biol. Chem. In press.
35. Dal Canton, A., R. Stanziale, A. Corradi, E. Vittorio, A. Migone, and L. Migone. 1977. Effects of acute ureteral obstruction on glomerular hemodynamics in rat kidney. Kidney Int. 12:403-411.
36. Harris, R.H., and J.M. Gill. 1981. Changes in glomerular filtration rate during complete ureteral obstruction in rats. Kidney Int. 19:603-608.
37. Lewellan, C.G., M. Berman, and J.E. Rall. 1959. Studies of iodoalbumin metabolism. I. A mathmatical approach to the kinetics. J. Clin. Invest. 38:66-87.
38. Harrison, D., J.H. Phillips, and L.L. Lanier. 1991. Involvement of a metalloproteinase in spontaneous and phorbol ester-induced release of natural killer cell-associated FcγRIII (CD16-II). J. Immunol. 147:3459-3465.
39. Gearing, A.J.H., P. Beckett, M. Christodoulou, M. Churchill, J. Clements, A.H. Davidson, A.H. Drummond, R. Gilbert, J.L. Gordon, T.M. Leber. 1994. Processing of tumour necrosis factor-α precursor by metalloproteinases. Nature (Lond.). 370:555-557.
40. Mullberg, J., W. Oberthur, F. Lottspeich, E. Mehl, E. Dittrich, L. Graeve, P.C. Heinrich, and S. Rose-John. 1994. The soluble human IL6 receptor: mutational characterization of the proteolytic cleavage site. J. Immunol. 152:4958-1968.
41. Zhang, L., and B.B. Aggarwal. 1994. Role of sulfhydryl groups in induction of cell surface down-modulation and shedding of extracellular domain of human TNF receptors in human histiocytic lymphoma U937 cells. J. Immunol. 153: 3745-3754.
42. Bazil, V. and J.L. Strominger. 1991. Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes. J. Immunol. 147:1567-1574.
43. Letelher, M., T. Nakajima, G. Pulido-Cejudo, H. Hofstetter, and G. Delepesse. 1990. Mechanism of formation of human IgE-binding factors (soluble CD23): III. Evidence for a receptor (Fc∈RII)-associated proteolytic activity. J. Exp. Med. 172:693-700.
44. Momson, T.G. 1988. Structure, function and intracellular processing of paramyxovirus membrane proteins. Virus Res 10.113-136.
45. Paulson, J.C. 1990. Glycoproteins: what are the sugar chains for? In Proteins: Form and Function. R.A. Bradshaw and M. Purton, eds. Elsevier Trends Journals, Cambridge. p. 272-276.
46. Rutledge. E.A., B.J. Root, J.J. Lucas, and C.A. Enns. 1994. Elimination of O-linked glycosylation site at Thr 104 results in the generation of a soluble human transferrin receptor Blood 83:580-586.
47. Miedel, M.C., J.O. Hulmes, D.V. Weber, P. Bailon, and Y.E. Pan. 1988. Structural analysis of recombinant soluble human interleukin-2 receptor. Biochem. Biophys. Res. Commun. 154:372-379.
48. Wano, Y., T. Uchiyama, J. Yodoi, and H. Uchino. 1985. Biosynthetic processing of human interleukin-2 receptor (Tac antigen). Microbiol. Immunol. 29:451-466.
49. Sato, H., T. Takino, Y. Okada, J. Cao, A. Shinagawa, E. Yamamoto, and M. Seiki. 1994. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature (Lond.) 370:61-65.
50. Ochs, H.R., and T.W. Smith. 1977. Reversal of advanced digitoxin toxicity and modification of pharmacokinetics by specific antibodies and Fab fragments. J. Clin. Invest. 60: 1303-1313.
51. 131I metabolism in human subjects: demonstration of insulin binding globulin in the circulation of insulin-treated subjects. J. Clin. Invest. 35:170-190.
52. Brambell, F.W.R., W.A. Hemmings, and I.G. Morris. 1964. A theoretical model of γ-globulin catabolism. Nature (Lond.). 203:1352-1355.
53. Brambell, F.W.R. 1966. The transmission of immunity from mother to young and the catabolism of immunoglobulins. Lancet. 2:1087-1093.
54. Waldmann, T.A., and E.A. Jones. 1977. The role of cell-surface receptors in the transport and catabolism of immunoglobulins. In Protein Turnover, CIBA Found Symp. 9:5-18.
55. Schmid, S.L., R. Fuchs, P. Male, and I. Mellman. 1988. Two distinct subpopulations of endosomes involved in membrane recycling and transport to lysosomes. Cell. 52:73-83.
56. Story, C.M., J.E. Mikulska, and N.E. Simister. 1994. A major histocompatibility complex class I-like Fc receptor cloned from human placenta: possible role in transfer of immunoglobulin G from mother to fetus. J. Exp. Med. 180:2377-2381.
57. West, M.A., J.M. Lucoca, and C. Watts. 1994. Antigen processing and class II MHC peptide-loading compartments in human B-lymphoblastoid cells. Nature (Lond.). 369:147-149.
58. Henderson, L.A., J.W. Baynes, and S.R. Thorpe. 1982. Identification of sites of IgG catabolism in the rat. Arch. Biochem. Biophys. 215:1-11.
59. Finkelman, F.D., K.B. Madden, S.C. Morris, J.M. Holmes, N. Boiani, I.M. Katona, and C.R. Maliszewski. 1993. Anti-cytokine antibodies as carrier proteins. J. Immunol. 151:1235-1244.
60. Goldenberg, D.M., A. Neville, A. Carter, V.L. Go, E.D. Holyoke, K.J. Isselbacher, P.S. Schein, and M. Schwartz. 1981. CEA (carcmoembryonic antigen): Its role as a marker in the management of cancer. J. Cancer Res. Clin. Oncol. 101: 239-242.